Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.
Mafham MM, Staplin N, Emberson J, Haynes R, Herrington W, Reith C, Wanner C, Walker R, Cass A, Levin A, Fellström B, Jiang L, Holdaas H, Kasiske B, Wheeler DC, Landray MJ, Baigent C; SHARP Collaborative Group. Mafham MM, et al. Among authors: fellstrom b. Nephrol Dial Transplant. 2018 Feb 1;33(2):257-264. doi: 10.1093/ndt/gfw396. Nephrol Dial Transplant. 2018. PMID: 28088776 Free PMC article. Clinical Trial.
Why do we need a statin trial in hemodialysis patients?
Fellström BC, Holdaas H, Jardine AG. Fellström BC, et al. Kidney Int Suppl. 2003 May;(84):S204-6. doi: 10.1046/j.1523-1755.63.s84.10.x. Kidney Int Suppl. 2003. PMID: 12694345 Free article. Review.
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.
Fellström B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Logan JO, Pedersen TR; Assessment of Lescol in Renal Transplantation Study Investigators. Fellström B, et al. Kidney Int. 2004 Oct;66(4):1549-55. doi: 10.1111/j.1523-1755.2004.00919.x. Kidney Int. 2004. PMID: 15458450 Free article. Clinical Trial.
Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.
Fellström B, Holdaas H, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Staffler B, Pedersen TR; Assessment of Lescol in Renal Transplantation Study Investigators. Fellström B, et al. Transplantation. 2005 Jan 27;79(2):205-12. doi: 10.1097/01.tp.0000147338.34323.12. Transplantation. 2005. PMID: 15665769 Clinical Trial.
Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C; ALERT Study Group. Holdaas H, et al. Among authors: fellstrom b. Nephrol Dial Transplant. 2005 May;20(5):974-80. doi: 10.1093/ndt/gfh735. Epub 2005 Mar 22. Nephrol Dial Transplant. 2005. PMID: 15784644 Free article. Clinical Trial.
Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial.
Fellström B, Jardine AG, Soveri I, Cole E, Grönhagen-Riska C, Neumayer HH, Maes B, Gimpelewicz C, Holdaas H; Assessment of Lescol in Renal Transplantation trial. Fellström B, et al. Transplantation. 2005 May 15;79(9):1160-3. doi: 10.1097/01.tp.0000160764.35083.b8. Transplantation. 2005. PMID: 15880062 Clinical Trial.
286 results